adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction a one-year prospective studyadalimumab临床疗效与类风湿因子和anti-cyclic citrullinated肽抗体效价降低一年的前瞻性研究.pdfVIP

Available online /content/8/1/R3 Vol 8 No 1 Open Access Research article Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study 1 1 1 2 Fabiola Atzeni , Pierc